Statistics
Publications
1
Citations
44
H-Index
1
Active since
2018
Affiliations
Mercy St. Vincent Medical Center(Current)
Satya Upadyayula is an author at Mercy St. Vincent Medical Center specializing in sodium-glucose cotransporter 2 inhibitors, type 2 diabetes pharmacotherapy, and diabetes pharmacotherapy.
Publications per year
2018–2018
1
1
Risks vs Benefits for SGLT2 Inhibitor Medications.
Shanti Pittampalli, Satya Upadyayula, Hema Madhuri Mekala et al. · PubMed · 2018 · 44 citations
1–1 of 1